For patients considering Human Microbiota Therapy
Human Microbiota Therapy (HMT) has been used as a therapy for gastrointestinal diseases for decades, but only recently has become the object of focused study and application. Currently, fecal microbiota transplant or HMT is being used in dozens of countries around the world, including the US, UK, Australia and Israel, as a treatment for Clostridium Difficile infection (CDI). FMT is generally effective more than 90 percent of the time as a treatment for CDI. In the US, the FDA has allowed clinicians to provide FMT to recurrent C. difficile patients.
Currently, FMT is also being researched as a treatment for many gastrointestinal related diseases, including Inflammatory Bowel Disease (Crohn’s Disease, Ulcerative Colitis), Irritable Bowel Syndrome, and other chronic digestive diseases. Medical clinics and FMT treatment centers in the UK and Australia have reported cases of successfully treating these diseases and conditions.
 Choi HH, Cho Y-S. Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clinical Endoscopy. 2016;49(3):257-265. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895930/)
 Shi Y, Dong Y, Huang W, Zhu D, Mao H, Su P. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Singh UP, ed. PLoS ONE. 2016;11(6): e0157259. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905678/)
 Kang D-W, Adams JB, Gregory AC, et al. Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017;5:10. doi:10.1186/s40168-016-0225-7. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264285/) (80% reduction in ASD GI Symptoms and 24% improvement in Childhood Autism Rating Scale (CARS), which rates core ASD symptoms after 8 weeks of no treatment)
 Li N, Tian H, Ma C, Ding C, Ge X, Gu L, Zhang X, Yang B, Hua Y, Zhu Y, Zhou Y. Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Jan 25;20(1):40-46.
 Paramsothy, Sudarshan et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. The Lancet, Volume 389 , Issue 10075 , 1218 – 1228
*The research above is a small sample size and representative of a single example of the efficacy of HMT. Previous success rates in clinical research are no guarantee of future remission.